Printer-Friendly Version

8:00 am: Registration

8:30 - 9:00 am: Welcome and Introductions

Dr. Ronald Waldman
Professor of Clinical Population & Family Health and Deputy Director of the Center for Global Health and Economic Development, Mailman School of Public Health, Columbia University

Dr. Fatomata Nafo-Traore
Director, Roll Back Malaria, World Health Organization

Dr. Pascal Villeneuve
Chief, Health Section, UNICEF

Dr. Jean-Marie Kindermans
President, MSF Belgium and Malaria Coordinator for MSF's Access to Essential Medecines Campaign

9:00 - 10:30 Session 1: The Need for Change
Chair: Dr. Allan Rosenfield, Dean and Director of the Center for Global Health and Economic Development, Mailman School of Public Health, Columbia University

WHO Policy on ACT
Dr. Kamini Mendis, Senior Advisor, Roll Back Malaria, World Health Organization

MSF's Experience Changing Policy on Diagnosis and Treatment Protocols in the Field
Dr. Christa Hook, Chair, MSF Malaria Working Group

10:45 - 12:15 Session 2: Current Approaches of Donor Community Towards Implementation of ACT
Chair: Prof. Nick White, Professor of Tropical Medicine, Mahidol University

Burundi Policy Revision: Lessons for International Partnership From a Successful Experience on the Ground
Dr. Dennis Carroll, Senior Health Advisor, United States Agency for International Development

DFID Support of the Uganda Transition Strategy and Plans for Moving Toward ACT
Dr. Stewart Tyson, Deputy Head of Health, Department for International Development, United Kingdom

Global Fund Strategy to Support Introduction of Improved Malaria Treatment
Dr. Vinand Nantulya, Senior Advisor, Global Fund to Fight AIDS, Tuberculosis and Malaria

How to Address the Significant Increase in Price of Malaria Treatments
Olusoji Adeyi, Lead Health Specialist, World Bank

12:15 - 1:30 - LUNCH

1:30 - 2:30 pm - Designing Development Assistance to Create Incentives for Rational Use of Antimalarial Drugs
Dean Jamison, Professor of Education and of Public Health at UCLA, Fellow at the Fogerty International Center of the National Institutes of Health, and Chairman of Institute of Medicine's Board on Global Health

2:45-4:00 Session 3: How Countries are Changing Policies
Chair: Dr. Awa Marie Coll-Seck, Executive Secretary, Roll Back Malaria Partnership

Zambia: A High-Prevalence Country Undergoing Transition to ACT
Ms. Masela Sekeseke-Chinyama, Parasitologist, Zambia National Malaria Control Program

Phased Introductions: The Case of Southeast Asia
Dr. Le Dinh Cong, Former Director, Vietnam National Malaria Control Program

4:15 - 5:45 Session 4: Home-Based Care and Community-Based Intervention
Chair: Dr. Awash Teklehaimanot, Center for Global Health and Economic Development, Mailman School of Public Health, Columbia University
Co-Chair, Dr. Christa Hook, MSF

Overview of Home-Based Care and Community-Based Intervention Strategies and Experience
Dr. Lulu Muhe, Medical Officer, World Health Organization

UNICEF's Approach to Community-Based Intervention
Dr. Kopano Mukelabai, Senior Medical Advisor, UNICEF

Using Rapid Diagnostic Tests in Community-Based Intervention in Ethiopia
Dr. Tedros Adhanom Ghebreyesus, Head of Tigray Health Bureau, Ethiopia

Integrating Community Health Workers for Community-Based Treatment
Dr. Richard Allan, Director, MENTOR Initiative

Day 2: Workshops: Practical Implementation Issues
Two simultaneous 2-hour interactive sessions to map issues and progress:

9:00 - 11:00 Workshop 1: Production Challenges to Increasing Capacity and Supply of ACT
Moderator: Dr. Dennis Carroll, United States Agency for International Development

Report from Copenhagen Meeting
Steve Jarrett, Deputy Director, Supply Division, UNICEF

Raw Materials: What Are the Dynamics of Cultivation, Extraction and Production? What Would It Take to Increase Capacity?
Nelson Tan, Holleykin

Finished Product: What Are the Commercial Considerations for Scaling Up Production?
Pradeep Nambiar, Ipca
Philippe Baetz, Sanofi
Daniela Currie, Novartis

Proposals to Insure Timely Scaling Up
Margriet den Boer, MSF

9:00 - 11:00 Workshop 2: Availability, Production, and Cost-Effectiveness of Rapid Diagnostic Tests
Moderator: Daniel Berman, Coordinator, Access to Essential Medicines Campaign, MSF-France

Role of Clinical, Microscopy and Rapid Diagnostic Tests in High Transmission Zones: Emerging Evidence for Targeted Use of Diagnostic Tools
Allan Schapira, Coordinator, Malaria Policy and Strategy Team, World Health Organization

Diagnosis in Practice; Initial Scale-Up of ACT in Zambia
Ms. Masela Sekeseke-Chinyama, Parasitologist, Zambia National Malaria Control Program

Current Availability and Development of New RDTs
Martine Guillerm, MSF

Are RDTs Robust Enough for Widespread Scale-Up?
David Bell, World Health Organization, Manila

Economic Aspects of Introducing RDTs
Chantal Morel, London School of Hygiene and Tropical Medicine

Discussion: What Will the Ideal RDT Look Like for the Introduction of RDTs? Is there a need for financial subsidy or will the market drive development?

11:00 - 11:30 Final Keynote
Jeffrey Sachs, PhD, Director, Earth Institute, Columbia University

11:30 - 12:30 Report Back and Conclusions
Simultaneous workshops present results of their discussions.